These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 168228)

  • 1. Inhibition of ACTH response to oral and intravenous metyrapone by antiserotoninergic treatment in man.
    Cavagnini F; Panerai AE; Valentini F; Bulgheroni P; Peracchi M; Pinto M
    J Clin Endocrinol Metab; 1975 Jul; 41(1):143-8. PubMed ID: 168228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an antiserotoninergic drug, metergoline, on the ACTH and cortisol response to insulin hypoglycemia and lysine-vasopressin in man.
    Cavagnini F; Raggi U; Micossi P; Di Landro A; Invitti C
    J Clin Endocrinol Metab; 1976 Aug; 43(2):306-12. PubMed ID: 181396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of two antiserotoninergic drugs, methysergide and metergoline, on gastric acid secretion and gastrin release in healthy man.
    Caldara R; Ferrari C; Barbieri C; Romussi M; Rampini P; Telloli P
    Eur J Clin Pharmacol; 1980 Jan; 17(1):13-8. PubMed ID: 7371695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ACTH response to 24 hours oral metyrapone test in normal children (author's transl)].
    Delepine N; Desbois JC; Techenet J; Gueris J; Herrault A
    Sem Hop; 1980 May 18-25; 56(19-20):946-50. PubMed ID: 6251560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of metyrapone on plasma corticotrophin immunoreactivity in normal man.
    Schöneshöfer M; Fenner A; Claus M
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):363-70. PubMed ID: 6307549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion.
    Brismar K; Werner S; Thorén M; Wetterberg L
    J Endocrinol Invest; 1985 Apr; 8(2):91-5. PubMed ID: 2993405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of immunoreactive beta-endorphin in normal human plasma: a concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration.
    Nakao K; Nakai Y; Oki S; Horii K; Imura H
    J Clin Invest; 1978 Dec; 62(6):1395-8. PubMed ID: 219030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma 11-deoxycortisol response to single dose metyrapone in prostatic cancer patients (author's transl)].
    Ohashi T; Morioka M; Akaeda T; Mitsuhata N; Takeda K; Ohmori H; Saito T; Takami T; Kanbegawa A
    Nihon Naibunpi Gakkai Zasshi; 1981 Jul; 57(7):983-96. PubMed ID: 6269918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the ACTH response to metyrapone by L-dopa in the monkey.
    Hsu TH; Hsu CK; Gann DS
    Endocrinology; 1976 Oct; 99(4):1115-8. PubMed ID: 185048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition.
    Van Vugt DA; Piercy J; Farley AE; Reid RL; Rivest S
    Endocrinology; 1997 Jun; 138(6):2249-58. PubMed ID: 9165008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Diabetologia; 1975 Apr; 11(2):165-7. PubMed ID: 1149950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.
    Jubiz W; Matsukura S; Meikle AW; Harada G; West CD; Tyler FH
    Arch Intern Med; 1970 Mar; 125(3):468-71. PubMed ID: 4313727
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamics of Adrenocorticotropin after Application of Metyrapone.
    Noe S; von Werder A; Iakoubov R; Schneider H; Thaler M; Luppa P; Neu B
    Exp Clin Endocrinol Diabetes; 2017 Jan; 125(1):53-56. PubMed ID: 27750352
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that cortisol inhibits basal adrenocorticotropin secretion in the sheep fetus by 0.70 gestation.
    Rose JC; Turner CS; Ray D; Rawashdeh N
    Endocrinology; 1988 Sep; 123(3):1307-13. PubMed ID: 2841090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
    Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
    J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.